Leading Four Channel Electrotherapy and Ultrasound System
Electrotherapy uses electrical currents to target specific areas on the body to reduce pain, improve circulation, and lead to other benefits in physical function. The TheraTouch CX4 can be used in combination with electrotherapy and ultrasound treatment using a four-channel therapy system. Users can adjust the intensity and parameter controls for each channel. The variance in energy transfer helps address diverse therapy needs for each individual using the device. The multi-patient function allows for treatment of up to 3 individuals at once.
Versatile Treatment Options with 8 Waveforms
Commonly used to relieve pain, the waveforms produced by the TheraTouch CX4 also improves joint range of motion, motor control, circulation, and muscle strength. Users can select stimulation waveforms from one of the eight waveforms: Interferential, Premodulated, TENS (Symmetrical Biphasic & Asymmetrical Biphasic), NMES, Russian, High Volt, Microcurrent, and RAAS. Rapid Agonist Antagonist Sequencing (RAAS) is a unique stimulation waveform that replicates the typical firing pattern of normal muscle contractions. The waveforms are designed to specifically improve weak and inhibited muscles following surgery, injury, or trauma.
Richmar Theratouch CX4 Equipped with a Touchscreen
Richmar TheraTouch CX4 is equipped with a menu-driven interface. The LCD color touchscreen is user-friendly and bilingual. The touchscreen serves as a comprehensive guide for medical professionals to use when carrying out clinical protocols. Using a step-by-step method, users are educated on treatment protocol to ensure the safety and effectiveness in electrotherapy and ultrasound use. In addition to the protocols, users can access an anatomical library for electrode placement recommendations.
![]()
WARNING: This product can expose you to chemicals including Cumene, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov





Reviews
There are no reviews yet.